Dimitry SA Nuyten
CIK 1776564 · Chief Medical Officer · last filed 2024-12-17
Dimitry SA Nuyten is a Chief Medical Officer who has filed 13 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider had shares withheld for taxes covering $126.3K of RCUS on Dec 17, 2024. Across all open-market trades the lifetime net is −$9.0K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $1.6M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ADRO price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
C/O ADURO BIOTECH, INC.
BERKELEY, CA 94710
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RCUS | Chief Medical Officer | 87,518 | $17.76 | $1.55M | $0 | 7 | 2024-12-17 |
| CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Chief Medical Officer | 8,462 | — | — | -$9.0K | 4 | 2020-08-11 |
Recent Filings
13 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-12-17 | RCUS | Tax (F) | −7,856 | -$126.3K | EDGAR |
| 2024-09-17 | RCUS | Tax (F) | −5,385 | -$96.7K | EDGAR |
| 2024-01-25 | RCUS | Grant (A) | +28,000 | $0 | EDGAR |
| 2023-12-20 | RCUS | Disp (D) | −3,047 | -$54.6K | EDGAR |
| 2023-12-15 | RCUS | Notice (144) | −3,500 | -$61.2K | EDGAR |
| 2023-09-20 | RCUS | Disp (D) | −3,708 | -$75.6K | EDGAR |
| 2023-09-15 | RCUS | Notice (144) | −6,000 | -$124.4K | EDGAR |
| 2023-01-25 | RCUS | Grant (A) | +34,000 | $0 | EDGAR |
| 2022-08-24 | RCUS | Grant (A) | +42,500 | $0 | EDGAR |
| 2020-08-11 | CHINOOK THERAPEUTICS, INC. (ADRO) Delisted | Sell (S) | −3,538 | -$9.0K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.